Validation of the shake test for detecting freeze damage to adsorbed vaccines;Validación de la prueba de agitación para detectar daños por congelación en las vacunas adsorbidas

Bulletin of the World Health Organization

Volumn 88, Issue 8, 2010, Pages 624-631

  Kartoglu, Ümit ^a   Özgüler, Nejat Kenan ^b   Wolfson, Lara J ^a   Kurzatkowski, Wiesław ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Karaman Hayat Medical Centre   (Turkey)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BACTERIAL VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; TETANUS TOXOID; VIRUS VACCINE;

DETECTION METHOD; HEALTH WORKER; SENSITIVITY ANALYSIS; VACCINE; WORLD HEALTH ORGANIZATION;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; CRYSTAL STRUCTURE; DRUG EFFICACY; DRUG QUALITY; DRUG STORAGE; HEALTH CARE PERSONNEL; INTERMETHOD COMPARISON; PHASE CONTRAST MICROSCOPY; PRECIPITATION; PREDICTION; SENSITIVITY AND SPECIFICITY; SHAKE TEST; VALIDATION STUDY; WORLD HEALTH ORGANIZATION;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG STABILITY; EVALUATION STUDIES AS TOPIC; FREEZING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VACCINES;

HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 77955999509     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.056879     Document Type: Article

References (21)

1. Milstien J, Kartoglu U, Zaffran M. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006 (unpublished document WHO/IVB/06.10)
2. Burgess MA, McIntyre PB. Vaccines and the cold chain: is it too hot.or too cold? Med J Aust 1999;171:82. PMID:10474582
3. Milhomme P. Cold chain study: danger of freezing vaccines. Can Commun Dis Rep 1993;19:33-8. PMID:8467304
4. Lugosi L, Battersby A. Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. Bull World Health Organ 1990;68:431-9. PMID:2208556
5. Hanjeet K, Lye MS, Sinniah M, Schnur A. Evaluation of cold chain monitoring in Kelantan, Malaysia. Bull World Health Organ 1996;74:391-7. PMID:8823961
6. Jeremijenko A, Kelly H, Sibthorpe B, Attewell R. Improving vaccine storage in general practice refrigerators. BMJ 1996;312:1651-2. PMID:8664720
7. Thakker Y, Woods S. Storage of vaccines in the community: weak link in the cold chain? BMJ 1992;304:756-8. doi:10.1136/bmj.304.6829.756 PMID:1571683
8. Wawryk A, Mavromatis C, Gold M. Electronic monitoring of vaccine cold chain in a metropolitan area. BMJ 1997;315:518. PMID:9329306
9. Bishai DM, Bhatt S, Miller LT, Hayden GF. Vaccine storage practices in pediatric offices. Pediatrics 1992;89:193-6. PMID:1734382
10. Bell KN, Hogue CJ, Manning C, Kendal AP. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001;107:e100. doi:10.1542/peds.107.6.e100 PMID:11389298
11. Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 2007;25:691-7. doi:10.1016/j.vaccine.2006.08.028 PMID:16968657
12. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007;25:3980-6. doi:10.1016/j.vaccine.2007.02.052 PMID:17382434
13. World Health Organization. The effects of freezing on the appearance, potency, and toxicity of adsorbed and unadsorbed DTP vaccines. Wkly Epidemiol Rec 1980;55:385-92.
14. Klotz SA, Normand R, Silberman R. Hepatitis B vaccine in healthy hospital employees. Infect Control 1986;7:365-9. PMID:3637168
15. Dimayuga R, Scheifele D, Bell A. Effects of freezing on DTP and DTP-IPV vaccines, adsorbed. Can Commun Dis Rep 1995;21:101-3. PMID:7647743
16. Dietz V, Galazka A, van Loon F, Cochi S. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ 1997;75:81-93. PMID:9141753
17. Mansoor O, Pillans PI. Vaccine adverse events reported in New Zealand 1990-95. N Z Med J 1997;110:270-2. PMID:9269289
18. World Health Organization. Guideline for establishing or improving primary and intermediate vaccine stores. Geneva: WHO; 2002 (WHO/V&B/02.34).
19. Aleksandrowicz J, Drozdz M, Fiejka M, Kurzatkowski W. Evaluation of the physico-chemical state of aluminium hydroxide in biopreparations stored in various conditions [in Polish]Exp Med Microbiol 1990;42:163-70.
20. Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine 2007;25:1328-33. doi:10.1016/j.vaccine.2006.09.092 PMID:17157419
21. Grover A, Amarjeet S, Aggarwal AK, Thakur JS. Does Indian version shake test correctly identify frozen damage vaccines? Bull Postgrad Inst Med Educ Res Chandigarh 2004;38:125-30.